Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT05134142
- Status
- Recruiting
Conditions
- Malignant Primary Pelvic Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Electronic Health Record Review — OTHERUndergo medical record review
- Physical Performance Testing — OTHERUndergo physical performance testing
- Quality-of-Life Assessment — OTHERComplete assessments
- Questionnaire Administration — OTHERComplete questionnaire
Study Details
This study aims to determine the functional outcomes of patients who underwent internal hemipelvectomy with or without reconstruction or external hemipelvectomy for pelvic tumors. Learning about the outcomes of these patients may help researchers determine the long-term effects of different types of hemipelvectomy procedures and may help improve quality of life.
Key Dates
- Start date
- Mar 27, 2013
- Status verified
- May 2026
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Observational (Physical tests, questionnaires, record review)Patients undergo physical performance assessments and complete quality of life assessments and questionnaires pre-hemipelvectomy, at 6 weeks post-hemipelvectomy, and then every 3 months up to 12 months and yearly thereafter for 10 years. Patients who are 1 year out from surgery complete pain-related questionnaires once. Patients who have already undergone hemipelvectomy prior to enrollment undergo medical record review.
Primary Outcome Measure
Functions of patients who underwent internal hemipelvectomy with or without reconstruction or have had an external hemipelvectomy [ Time Frame: Through study completion, average of 1 year ]
Central Contacts
- Valerae O Lewis713-792-5073
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Valerae O. Lewis 713-792-5073 Valerae O. Lewis (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site